Global Disease Detection and Response Program, US Naval Medical Research Unit No. 3, Cairo, Egypt.
Am J Infect Control. 2011 Nov;39(9):e61-5. doi: 10.1016/j.ajic.2011.04.009. Epub 2011 Aug 11.
Nosocomial bloodstream infections (BSIs) and antimicrobial resistance (AMR) are worldwide health care problems causing substantial patient morbidity and mortality. This study was conducted to identify bacterial pathogens isolated from nosocomial BSIs and determine their AMR patterns.
An active surveillance program for BSIs was conducted in intensive care units in 3 large university hospitals in Egypt between September 1, 2006, and June 30, 2007. Infection prevention and control teams and link nurses in collaboration with intensive care physicians were looking actively to identify patients who acquired BSIs based on Centers for Disease Control and Prevention standard case definitions. Blood cultures were obtained from patients with suspected BSIs and processed to isolate bacteria and test their antimicrobial resistance.
During the 10-month active surveillance period, a total of 600 pathogens were isolated from blood cultures of 1,575 patients (38%). Of these 600 isolates, 386 (66%) were gram-negative, 178 (30%) were gram-positive, and 24 (4%) were budding yeasts. The gram-negative organisms included 162 (27%) Klebsiella pneumoniae and 23 (3.8%) Escherichia coli. Extended-spectrum β-lactamase enzymes were detected in 79% of the K pneumoniae isolates and 39% of the E coli isolates. Methicillin-resistant Staphylococcus aureus accounted for 60% of S aureus infections.
High rates of β-lactamase resistance and methicillin-resistant S aureus were found in the 3 Egyptian university hospitals studied. This study highlights the need for strengthening infection prevention and control programs, monitoring AMR at each facility, and developing policies for antibiotic use.
医院获得性血流感染(BSI)和抗菌药物耐药性(AMR)是全球性的医疗保健问题,导致患者发病率和死亡率显著增加。本研究旨在确定从医院获得性 BSI 中分离出的细菌病原体,并确定其 AMR 模式。
2006 年 9 月 1 日至 2007 年 6 月 30 日,在埃及的 3 所大型大学医院的重症监护病房中进行了一项针对 BSI 的主动监测计划。感染预防和控制团队以及联络护士与重症监护医师合作,积极寻找根据疾病控制和预防中心标准病例定义发生 BSI 的患者。从疑似 BSI 患者的血液中采集血培养物,并进行处理以分离细菌并测试其抗菌药物耐药性。
在 10 个月的主动监测期间,从 1575 名患者的血培养中总共分离出 600 种病原体(38%)。在这 600 个分离株中,386 株(66%)为革兰氏阴性菌,178 株(30%)为革兰氏阳性菌,24 株(4%)为出芽酵母。革兰氏阴性菌包括 162 株(27%)肺炎克雷伯菌和 23 株(3.8%)大肠杆菌。79%的肺炎克雷伯菌和 39%的大肠杆菌分离株检测到超广谱β-内酰胺酶酶。耐甲氧西林金黄色葡萄球菌占金黄色葡萄球菌感染的 60%。
在研究的 3 所埃及大学医院中发现了高比例的β-内酰胺酶耐药和耐甲氧西林金黄色葡萄球菌。本研究强调需要加强感染预防和控制计划,监测每个医疗机构的 AMR,并制定抗生素使用政策。